Stem cell therapies in the clinic

被引：1

作者：

Acharya, Shrinivas ^{[1
,2
]}

Shaha, Suyog ^{[1
,2
]}

Bibbey, Michael Griffith ^{[1
,2
]}

Mukherji, Malini ^{[1
,2
]}

Zhao, Zongmin ^{[3
]}

Mitragotri, Samir ^{[1
,2
]}

机构：

[1] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Allston, MA 02138 USA

[2] Harvard Univ, Wyss Inst Biolog Inspired Engn, Boston, MA 02115 USA

[3] Univ Illinois, Coll Pharm, Dept Pharmaceut Sci, Chicago, IL 60607 USA

来源：

BIOENGINEERING & TRANSLATIONAL MEDICINE | 2025年

基金：

美国国家卫生研究院; 美国国家科学基金会;

关键词：

cell; cell therapy; clinical translation; clinical trials; HSC; iPSC; MSC; stem cell; PROOF-OF-CONCEPT; BONE-MARROW; STROMAL CELLS; DIABETES-MELLITUS; TRANSPLANTATION; EFFICACY; PROGRESS; SAFETY; DONOR; OSTEOARTHRITIS;

D O I：

10.1002/btm2.70000

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Stem cell therapies have emerged as a transformative approach in modern medicine, with the potential to address and possibly cure a broad spectrum of diseases. These therapies utilize living stem cells that can perform complex biological functions not replicable by traditional drugs. Stem cell therapies have an expanding therapeutic landscape, with several products already approved and numerous clinical trials underway. Among the various stem cell types, hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) are most widely studied. In this review, we provide a detailed analysis of the current clinical landscape of stem cell therapies. We review 27 stem cell products that have received regulatory approvals and discuss 800 ongoing clinical trials, with a focus on HSCs and MSCs. We also discuss the critical challenges to be addressed to facilitate the clinical translation of stem cell therapies.

引用

页数：25

共 50 条

[21] Efficacies of Stem Cell Therapies for Functional Improvement of the β Cell in Patients with Diabetes: A Systematic Review of Controlled Clinical Trials
Hwang, Gyudeok
Jeong, Hyunsuk
Yang, Hae Kyung
Kim, Hun-Sung
Hong, Hanter
Kim, Na Jin
Oh, Il-Hoan
Yim, Hyeon Woo
INTERNATIONAL JOURNAL OF STEM CELLS, 2019, 12 (02) : 195 - 205
[22] Engineering better stem cell therapies for treating heart diseases
Li, Junlang
Hu, Shiqi
Cheng, Ke
ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (08)
[23] Stem Cell Therapies for the Treatment of Diabetic Neuropathies: Future Perspectives
de Figueiredo, Camila Saggioro
dos Reis, Luiz Carlos
CURRENT DIABETES REVIEWS, 2021, 17 (01) : 2 - 10
[24] Stem cell therapies for neuropathic pain
Seewoodhary, Jason
Harvey, John N.
BRITISH JOURNAL OF DIABETES AND VASCULAR DISEASE, 2014, 14 (01) : 2 - 9
[25] Nanotechnology for mesenchymal stem cell therapies
Corradetti, Bruna
Ferrari, Mauro
JOURNAL OF CONTROLLED RELEASE, 2016, 240 : 242 - 250
[26] Stem cell therapies for neuromuscular diseases
Partridge, TA
ACTA NEUROLOGICA BELGICA, 2004, 104 (04) : 141 - 147
[27] Stem cell therapies for retinal diseases: from bench to bedside
Shen, Yuening
JOURNAL OF MOLECULAR MEDICINE-JMM, 2020, 98 (10): : 1347 - 1368
[28] Mesenchymal stem cell related therapies for cartilage lesions and osteoarthritis
Zhang, Rui
Ma, Jie
Han, Jing
Zhang, Weijie
Ma, Jianbing
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (10): : 6275 - 6289
[29] Experimental stem cell therapies on burn wound: Do source, dose, timing and method matter?
Ozturk, Sinan
Karagoz, Huseyin
BURNS, 2015, 41 (06) : 1133 - 1139
[30] Advanced clinical imaging for the evaluation of stem cell based therapies
Klontzas, Michail E.
Kakkos, George A.
Papadakis, Georgios Z.
Marias, Kostas
Karantanas, Apostolos H.
EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (09) : 1253 - 1264

← 1 2 3 4 5 →